ATYR
Price
$2.95
Change
+$0.07 (+2.43%)
Updated
Apr 2, 04:59 PM (EDT)
Capitalization
263.02M
34 days until earnings call
DRUG
Price
$35.31
Change
-$0.80 (-2.22%)
Updated
Apr 2 closing price
Capitalization
248.98M
Ad is loading...

ATYR vs DRUG

Header iconATYR vs DRUG Comparison
Open Charts ATYR vs DRUGBanner chart's image
aTyr Pharma
Price$2.95
Change+$0.07 (+2.43%)
Volume$15.26K
Capitalization263.02M
Bright Minds Biosciences
Price$35.31
Change-$0.80 (-2.22%)
Volume$47.58K
Capitalization248.98M
ATYR vs DRUG Comparison Chart
Loading...
ATYR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
DRUG
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ATYR vs. DRUG commentary
Apr 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATYR is a StrongBuy and DRUG is a Buy.

Ad is loading...
COMPARISON
Comparison
Apr 03, 2025
Stock price -- (ATYR: $2.88 vs. DRUG: $35.31)
Brand notoriety: ATYR and DRUG are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ATYR: 118% vs. DRUG: 93%
Market capitalization -- ATYR: $263.02M vs. DRUG: $248.98M
ATYR [@Biotechnology] is valued at $263.02M. DRUG’s [@Biotechnology] market capitalization is $248.98M. The market cap for tickers in the [@Biotechnology] industry ranges from $308.32B to $0. The average market capitalization across the [@Biotechnology] industry is $2.19B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ATYR’s FA Score shows that 0 FA rating(s) are green whileDRUG’s FA Score has 0 green FA rating(s).

  • ATYR’s FA Score: 0 green, 5 red.
  • DRUG’s FA Score: 0 green, 5 red.
According to our system of comparison, DRUG is a better buy in the long-term than ATYR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ATYR’s TA Score shows that 4 TA indicator(s) are bullish while DRUG’s TA Score has 3 bullish TA indicator(s).

  • ATYR’s TA Score: 4 bullish, 5 bearish.
  • DRUG’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, both ATYR and DRUG are a bad buy in the short-term.

Price Growth

ATYR (@Biotechnology) experienced а -17.48% price change this week, while DRUG (@Biotechnology) price change was -0.73% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -5.27%. For the same industry, the average monthly price growth was -7.37%, and the average quarterly price growth was -12.08%.

Reported Earning Dates

ATYR is expected to report earnings on May 07, 2025.

DRUG is expected to report earnings on Aug 28, 2023.

Industries' Descriptions

@Biotechnology (-5.27% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ATYR($263M) has a higher market cap than DRUG($249M). DRUG YTD gains are higher at: -1.971 vs. ATYR (-20.442). DRUG has higher annual earnings (EBITDA): -2.67M vs. ATYR (-66.37M). ATYR has more cash in the bank: 72.1M vs. DRUG (57.9M). DRUG has less debt than ATYR: DRUG (183K) vs ATYR (13.3M). ATYR has higher revenues than DRUG: ATYR (235K) vs DRUG (0).
ATYRDRUGATYR / DRUG
Capitalization263M249M106%
EBITDA-66.37M-2.67M2,484%
Gain YTD-20.442-1.9711,037%
P/E RatioN/AN/A-
Revenue235K0-
Total Cash72.1M57.9M125%
Total Debt13.3M183K7,268%
FUNDAMENTALS RATINGS
ATYR: Fundamental Ratings
ATYR
OUTLOOK RATING
1..100
57
VALUATION
overvalued / fair valued / undervalued
1..100
81
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
47
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ATYRDRUG
RSI
ODDS (%)
Bullish Trend 2 days ago
73%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
85%
Momentum
ODDS (%)
Bearish Trend 2 days ago
84%
Bullish Trend 2 days ago
83%
MACD
ODDS (%)
Bearish Trend 2 days ago
81%
Bullish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
84%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
89%
Advances
ODDS (%)
Bullish Trend 21 days ago
80%
Bullish Trend 6 days ago
85%
Declines
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 14 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
88%
N/A
Aroon
ODDS (%)
N/A
N/A
View a ticker or compare two or three
Ad is loading...
ATYR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
DRUG
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
QTELX10.620.03
+0.28%
AQR Emerging Multi-Style II I
ESMYX14.82N/A
N/A
Invesco EQV Euro Small Company Y
FGIPX15.13N/A
N/A
Macquarie Growth and Income Instl
TILPX25.71N/A
N/A
Nuveen Large Cap Growth Premier
PAHWX7.58N/A
N/A
PGIM Jennison Intl Sm-Md Cap Opps A

ATYR and

Correlation & Price change

A.I.dvisor indicates that over the last year, ATYR has been loosely correlated with MGTX. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if ATYR jumps, then MGTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATYR
1D Price
Change %
ATYR100%
-4.64%
MGTX - ATYR
43%
Loosely correlated
-9.14%
NTLA - ATYR
36%
Loosely correlated
-6.40%
SLDB - ATYR
35%
Loosely correlated
-6.89%
ARWR - ATYR
34%
Loosely correlated
-4.20%
AMLX - ATYR
34%
Loosely correlated
-5.65%
More